BioNTech SE Other Comprehensive Income Net Of Tax Exchange Differences On Translation
BioNTech SE (BNTX) reported Other Comprehensive Income Net Of Tax Exchange Differences On Translation of -EUR 99.30 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Income Statement › Unrealized Gains
ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation · last filed 2026-03-10
| Period end | Other Comprehensive Income Net Of Tax Exchange Differences On Translation 12 month | Other Comprehensive Income Net Of Tax Exchange Differences On Translation 12 month as first filed |
|---|---|---|
| 2025-12-31 | -99.30M EUR 20-F · filed 2026-03-10 | |
| 2024-12-31 | 43.50M EUR 20-F · filed 2026-03-10 | |
| 2023-12-31 | -19.80M EUR 20-F · filed 2026-03-10 | |
| 2022-12-31 | 11.20M EUR 20-F · filed 2025-03-10 | |
| 2021-12-31 | 8.40M EUR 20-F · filed 2024-03-20 | |
| 2020-12-31 | -11.10M EUR 20-F · filed 2023-03-27 | -11.10M EUR 20-F · filed 2021-03-30 |
| 2019-12-31 | 100.00K EUR 20-F/A · filed 2022-10-26 | 77.00K EUR 20-F · filed 2020-03-31 |
| 2018-12-31 | 10.00K EUR 20-F · filed 2021-03-30 | |
| 2017-12-31 | -23.00K EUR 20-F · filed 2020-03-31 |